May 5 2010  |  News Release 

The new simulator enables patients to benefit from faster and more precise cancer radiation treatments 

A Simulix Evolution has recently gone into operation in the Regional Clinical Oncology Centre of Chelyabinsk, a major industrial city in the south of Russia. The new simulator enables patients to benefit from faster and more precise cancer radiation treatments, thanks to improved imaging and simulation techniques. Tumors can now be targeted with higher yet more precise doses of radiation, allowing healthy surrounding tissues to be spared.

 

Russian TV filmed the introduction of the Simulix as part of a news item, during which the Russian healthcare system was discussed and comparisons made with healthcare and radiotherapy elsewhere in the world. A short interview with Nucletron’s Jeroen Singelenberg also formed part of the item. This naturally provided an excellent occasion to emphasize the benefits of first-class radiotherapy equipment, and to enhance and strengthen the position of the R.C.O.C in Chelyabinsk as the leading institute in the region.

About Nucletron
Nucletron provides state-of-the-art radiotherapy solutions for cancer treatment that meet the evolving needs of patients, their careers and healthcare professionals around the world. Nucletron has unmatched global leadership in brachytherapy, a very precise, highly effective and well tolerated treatment option tailored to the needs of individual patients and able to meet the requirements of healthcare providers. We work with clinical teams to constantly improve and develop an innovative portfolio of integrated products, software and services that assures excellent patient outcomes. Headquartered in Veenendaal, the Netherlands, Nucletron employs more than 500 employees, with offices in 15 countries and products available in more than 100 countries around the world. Please visit http://www.nucletron.com/ to learn more about our healthcare solutions.

 
http://www.nucletron.com/
http://www.aboutbrachytherapy.com/